红润
发表于 2025-3-23 12:43:33
Optimal control of heating processes,as prompted investigation in many different disease models of conditioned medium (CM) obtained from culturing MSC. Seminal studies in rodent stroke models have validated the therapeutic potential of adipose stem/stromal cell (ASC) as well as MSC-CM, demonstrating a similar effect as with cell delive
Flounder
发表于 2025-3-23 14:21:17
http://reply.papertrans.cn/23/2229/222889/222889_12.png
Arthr-
发表于 2025-3-23 20:16:28
http://reply.papertrans.cn/23/2229/222889/222889_13.png
变化
发表于 2025-3-24 00:47:17
http://reply.papertrans.cn/23/2229/222889/222889_14.png
整洁漂亮
发表于 2025-3-24 02:21:59
Autologous Mesenchymal Stem Cell Therapy in Patients with Stroke,regulations on stem cell use for clinical applications will be discussed, from bench (diverse cell sources and culture processes) to bedside (patient selection, blood-brain barrier manipulation, and outcome measures).
chapel
发表于 2025-3-24 08:13:36
,Clinical Development of MultiStem® for Treatment of Injuries and Diseases of the Central Nervous Syntrolled phase I/II trial evaluating cell safety and efficacy in patients suffering an acute ischemic stroke. Aspects of the trial design and exploratory endpoints were developed as a function of preclinical animal testing with multiple different collaborative laboratories. A hypothesis emerged base
圣歌
发表于 2025-3-24 10:49:30
Intra-arterial Approaches to Stem Cell Therapy for Ischemic Stroke, attributes including minimally invasive and targeted delivery of cells to area of brain injury. This route of delivery of cells has been the focus of our laboratory and here we review the preclinical data and the recent rise in published early clinical trials of cell-based therapy in ischemic strok
英寸
发表于 2025-3-24 16:54:39
Induced Pluripotent Stem Cells as a Cell-Based Therapeutic in Stroke,development, choosing the optimal iPSC-derived neural progenitors to transplant, determining the ideal routes, timing, and doses of cell transplantation, and developing good manufacturing practices (GMP) to safely expand and maintain the cells for clinical use. While both autologous and allogeneic t
芳香一点
发表于 2025-3-24 19:12:56
http://reply.papertrans.cn/23/2229/222889/222889_19.png
palliate
发表于 2025-3-25 02:29:45
Preconditioning and Cell-Based Therapeutics,uch as stromal derived factor (SDF)-1 and erythropoietin also serve as “preconditioning” agents. Another approach is to “condition” the host tissue. A safe and feasible intervention, remote ischemic conditioning using a blood pressure cuff on the limbs, makes the host more receptive and responsive t